We are thought leaders in comparative effectiveness research (CER) and patient-centered outcomes research (PCOR).
CMTP focuses on novel efforts in research standards, research infrastructure, and policy.
Stay up to date with the latest CMTP news and industry happenings.
CMTP is strongly committed to the creation of public-private partnerships.
Browse industry research, articles, publications and other important resources by topic or content type.
The EGD provides guidance for improving the design, conduct, and reporting of late phase (approval and post-approval) drug studies for patients with type 2 diabetes. It includes specific recommendations for the design of prospective clinical studies that reflect the evidence expectations of payers, informed by the perspectives of patients, clinicians, and other decision makers. The recommendations are made in four major areas: population, outcomes, methods, and reporting for patient stakeholders.
As part of GPC-USA, the Endocrine-Metabolic Consortium will develop methodological standards for patient-centered outcomes research and comparative effectiveness research in endocrine and metabolic diseases.
Update on GPC-USA Endocrine-Metabolic Consortium provided at November 2013 Annual Meeting by Nisa Maruthur, Johns Hopkins University School of Medicine.